Growth Metrics

Nexalin Technology (NXL) EBIT (2021 - 2026)

Nexalin Technology's quarterly EBIT came in at -$2.1 million in Q1 2026, down 5.4% year-on-year from -$2.2 million in Q1 2025, and up 12.15% quarter-over-quarter from -$2.4 million in Q4 2025.

Nexalin Technology has reported EBIT for 6 years, with the latest figure at -$2.1 million in Q1 2026.

  • For the quarter ending Q1 2026, EBIT fell 5.4% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$8.5 million (up 2.22% YoY), and the FY2025 full-year result was -$8.4 million, down 8.2% from the prior year.
  • EBIT for Q1 2026 stood at -$2.1 million, up from -$2.4 million in the prior quarter.
  • The five-year high for EBIT was -$293194.0 in Q3 2022, with the low at -$2.9 million in Q4 2024.
  • Average EBIT over 5 years is -$1.5 million, with a median of -$1.6 million recorded in 2025.
  • Year-over-year, EBIT soared 83.67% in 2022 and tumbled 723.87% in 2023.
  • Tracing NXL's EBIT over 5 years: stood at -$719617.0 in 2022, then slumped by 125.74% to -$1.6 million in 2023, then slumped by 77.0% to -$2.9 million in 2024, then advanced by 16.08% to -$2.4 million in 2025, then advanced by 12.15% to -$2.1 million in 2026.
  • The last three EBIT figures came in at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.35 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 936.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.46 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.10 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 477.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 282.15 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 255.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 515.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 316.80 Mn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 -2.12 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.12 Mn
Dec 31, 2025 -2.41 Mn
Sep 30, 2025 -2.35 Mn
Jun 30, 2025 -1.62 Mn
Mar 31, 2025 -2.01 Mn
Dec 31, 2024 -2.88 Mn
Sep 30, 2024 -2.51 Mn
Jun 30, 2024 -1.30 Mn
Mar 31, 2024 -1.07 Mn
Dec 31, 2023 -1.62 Mn
Sep 30, 2023 -2.42 Mn
Jun 30, 2023 -876,860.00
Mar 31, 2023 -779,426.00
Dec 31, 2022 -719,617.00
Sep 30, 2022 -293,194.00
Jun 30, 2022 -445,103.00
Mar 31, 2022 -375,117.00
Dec 31, 2021 -577,489.00
Sep 30, 2021 -1.80 Mn